- Home
- JAZZ vs WBS Comparison
JAZZ vs WBS Comparison
Compare JAZZ & WBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- WBS
- Stock Information
- Founded
- JAZZ 2003
- WBS 1935
- Country
- JAZZ Ireland
- WBS United States
- Employees
- JAZZ N/A
- WBS N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- WBS Major Banks
- Sector
- JAZZ Health Care
- WBS Finance
- Exchange
- JAZZ Nasdaq
- WBS Nasdaq
- Market Cap
- JAZZ 6.7B
- WBS 8.9B
- IPO Year
- JAZZ 2007
- WBS N/A
- Fundamental
- Price
- JAZZ $112.30
- WBS $57.92
- Analyst Decision
- JAZZ Strong Buy
- WBS Buy
- Analyst Count
- JAZZ 12
- WBS 12
- Target Price
- JAZZ $183.08
- WBS $66.75
- AVG Volume (30 Days)
- JAZZ 644.7K
- WBS 1.4M
- Earning Date
- JAZZ 07-30-2025
- WBS 07-17-2025
- Dividend Yield
- JAZZ N/A
- WBS 2.75%
- EPS Growth
- JAZZ 49.21
- WBS N/A
- EPS
- JAZZ 7.51
- WBS 4.44
- Revenue
- JAZZ $4,064,808,000.00
- WBS $2,372,492,000.00
- Revenue This Year
- JAZZ $6.05
- WBS $9.90
- Revenue Next Year
- JAZZ $4.68
- WBS $5.07
- P/E Ratio
- JAZZ $14.96
- WBS $13.11
- Revenue Growth
- JAZZ 5.76
- WBS N/A
- 52 Week Low
- JAZZ $95.49
- WBS $39.43
- 52 Week High
- JAZZ $148.06
- WBS $63.99
- Technical
- Relative Strength Index (RSI)
- JAZZ 57.44
- WBS 60.26
- Support Level
- JAZZ $109.27
- WBS $58.58
- Resistance Level
- JAZZ $112.70
- WBS $59.74
- Average True Range (ATR)
- JAZZ 2.71
- WBS 1.34
- MACD
- JAZZ 0.47
- WBS 0.17
- Stochastic Oscillator
- JAZZ 90.37
- WBS 69.63
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About WBS Webster Financial Corporation
Webster Financial Corp is a full-service provider of financial services, offering commercial and consumer banking, mortgages, and investment advisory along with trust and wealth management services in Connecticut, New York, Rhode Island, Massachusetts, and Pennsylvania. The company's segment includes Commercial Banking, HSA Bank, and Consumer Banking. It generates maximum revenue from the Commercial Banking segment.